Xinguang Pharma released its first-quarter performance, with a net profit attributable to the parent company of 24.5418 million yuan, an increase of 7.50%

Xinguang Pharma released its Q1 2025 performance report, with operating revenue of 93.2501 million yuan, a year-on-year decrease of 7.26%. The net profit attributable to the parent company was 24.5418 million yuan, a year-on-year increase of 7.50%. The net profit after deducting non-recurring gains and losses was 23.3665 million yuan, a year-on-year increase of 9.49%. The basic earnings per share were 0.15 yuan